KAB Biotech Holding ApS: Financial statements 2017
CVR: 37692646
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
KAB Biotech Holding ApS (CVR 37692646) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -15,750 and a net result of DKK 457,159. Equity in the 2017 report amounted to DKK 7,260,448. The solvency ratio was 99.1%.
- Gross Profit
- DKK -15,750
- Profit/Loss
- DKK 457,159
- Equity
- DKK 7,260,448
- Total Assets
- DKK 7,327,448
Official annual report
Keep an eye on KAB Biotech Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
KAB Biotech Holding ApS has published its interim report for the period May 18, 2016 – December 31, 2016.
As of February 3, 2017, JS Revision, Godkendt Revisionsaktieselskab has been appointed auditor of KAB Biotech Holding ApS.
As of February 3, 2017, JS REVISION, STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of KAB Biotech Holding ApS.
About KAB Biotech Holding ApS
KAB Biotech Holding ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 17 August 2020. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK -17,000 and a net result of DKK 7,466,344 compared with DKK 9,892,311 the year before. Equity in the 2019 report amounted to DKK 24,619,103.